(Total Views: 421)
Posted On: 03/09/2021 12:25:37 PM
Post# of 155843
Re: ombowstring #82308
ombowstring wrote:
Has anyone analyzed the data and determined how LL fared in the severe population? I'm very surprised how the trial came out when doctor after doctor reported that their patients were walking out of hospitals after being treated with leronlimab.
My response:
Great question...
The severe treated with LL were NOT part of the 28% population that walked out healthy at day 28, vs 11% of SOC that walked out healthy at day 28. These were all critical.
The severe treated with LL were part NOT part of the folks that had a 6 day reduction in hospital stay. These folks were al critical.
Overall death reduction was "nominal", really low. Severe just don't die that much. Severe were a hight percent of overall population, I think 85% and 2/3 of our Critical were over 65 I think, Thses stat hurt us. Poor trial design has caused the crunch blood bath today and yesterday.
This holding on is wearing me down. When are shorts gonna start to cover for some rebound???
Has anyone analyzed the data and determined how LL fared in the severe population? I'm very surprised how the trial came out when doctor after doctor reported that their patients were walking out of hospitals after being treated with leronlimab.
My response:
Great question...
The severe treated with LL were NOT part of the 28% population that walked out healthy at day 28, vs 11% of SOC that walked out healthy at day 28. These were all critical.
The severe treated with LL were part NOT part of the folks that had a 6 day reduction in hospital stay. These folks were al critical.
Overall death reduction was "nominal", really low. Severe just don't die that much. Severe were a hight percent of overall population, I think 85% and 2/3 of our Critical were over 65 I think, Thses stat hurt us. Poor trial design has caused the crunch blood bath today and yesterday.
This holding on is wearing me down. When are shorts gonna start to cover for some rebound???
(1)
(0)
